EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review

Marco Valvano iD, Stefano Fabiani, Sabrina Monaco, Mauro Calabrò, Antonio Mancusi, Sara Frassino, Claudia Rolandi, Marta Mosca, Susanna Faenza, Emanuele Sgamma, Nicola Cesaro, Giovanni Latella iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241612800 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Marco Valvano und 11 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Unit, Division of Gastroenterology, Hepatology and Nutrition, Department of Life, Health and Environmental Sciences, University of L…. Hauptthemen laut MEDLINE: Celiac Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Celiac disease (CD) is a chronic enteropathy caused by the ingestion of gluten in a genetically susceptible individual. Currently, a gluten-free diet (GFD) is the only recommended treatment. However, unintentional gluten ingestion or a persistent villous atrophy with malabsorption (regardless of a strict GFD) as in the case of Refractory Celiac Disease (RCD) represents a major issue. In this review, we have analysed and discussed data from both randomized controlled trials and observational studies concerning adjunctive therapies as well as novel therapies for the treatment of CD and RCD. The literature search was carried out through Medline and Scopus. In total, 2268 articles have been identified and 49 were included in this review (36 studies resulting from the search strategy and 13 from other sources). Today, GFD remains the only effective treatment, although steroids, mesalamine, and more recently biological therapies have found space in the complex management of RCD. Currently, studies evaluating the effectiveness of novel therapies are still limited and preliminary results have been controversial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Celiac DiseaseHumansDental CareGlutensDiet, Gluten-FreeGenetic Predisposition to Disease

Stichwörter der Autor:innen

celiac diseasecorticosteroidmesalaminerefractory celiac diseasesmall molecules

Substanzen

Glutens

Autor:innen und Institutionen

  • Gastroenterology Unit, Division of Gastroenterology, Hepatology and Nutrition, Department of Life, Health and Environmental Sciences, University of L'Aquila, Piazzale Salvatore Tommasi 1, 67100 L'Aquila, Italy.

ORCID-Profile: Marco Valvano, Giovanni Latella

Zitieren

APA

Valvano, M., Fabiani, S., Monaco, S., Calabrò, M., Mancusi, A., Frassino, S., Rolandi, C., Mosca, M., Faenza, S., Sgamma, E., Cesaro, N., & Latella, G. (2023). Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241612800

Vancouver

Valvano M, Fabiani S, Monaco S, Calabrò M, Mancusi A, Frassino S, et al. Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241612800

BibTeX
@article{Valvano2023,
  author = {Valvano, Marco and Fabiani, Stefano and Monaco, Sabrina and Calabrò, Mauro and Mancusi, Antonio and Frassino, Sara and Rolandi, Claudia and Mosca, Marta and Faenza, Susanna and Sgamma, Emanuele and Cesaro, Nicola and Latella, Giovanni},
  title = {Old and New Adjunctive Therapies in Celiac Disease and Refractory Celiac Disease: A Review},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241612800}
}
Kostenlos starten →